Company intelligence / Profile preview

Eidogen-Sertanty

Oceanside, California, United States

Ownership: Private
Employees: ~15
Development stage: Other

Overview

Eidogen-Sertanty is a structural bioinformatics and cheminformatics company that provides software, databases, and services to accelerate drug discovery. Formed by the 2005 merger of Eidogen and Sertanty, the company specializes in structural drug design and target informatics. Their flagship products include the Kinase Knowledgebase (KKB), a comprehensive database of kinase SAR data, and the Target Informatics Platform (TIP). The company's technology enables researchers to perform comparative protein structure analysis and virtual screening to identify novel small molecule leads.

Therapeutic areas: OncologyImmunology
Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

Abbott LaboratoriesEli Lilly and CompanyMerck & Co.

Beyond the preview

Go deeper on Eidogen-Sertanty.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eidogen-Sertanty.

Explore the full profile